CN108685000A - 一种持续性缓解疲劳的功能饮料 - Google Patents
一种持续性缓解疲劳的功能饮料 Download PDFInfo
- Publication number
- CN108685000A CN108685000A CN201810492814.XA CN201810492814A CN108685000A CN 108685000 A CN108685000 A CN 108685000A CN 201810492814 A CN201810492814 A CN 201810492814A CN 108685000 A CN108685000 A CN 108685000A
- Authority
- CN
- China
- Prior art keywords
- extract
- drinks
- taurine
- fatigue
- sucrose inversion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical group NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000000284 extract Substances 0.000 claims abstract description 26
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 23
- 229930006000 Sucrose Natural products 0.000 claims abstract description 23
- 239000005720 sucrose Substances 0.000 claims abstract description 23
- 239000000796 flavoring agent Substances 0.000 claims abstract description 22
- 235000019634 flavors Nutrition 0.000 claims abstract description 22
- 241000893536 Epimedium Species 0.000 claims abstract description 19
- 235000018905 epimedium Nutrition 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 12
- 229960003080 taurine Drugs 0.000 claims description 19
- 241001165494 Rhodiola Species 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 235000020237 cranberry extract Nutrition 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 235000013361 beverage Nutrition 0.000 abstract description 5
- 230000002641 glycemic effect Effects 0.000 abstract description 4
- 230000002035 prolonged effect Effects 0.000 abstract description 4
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 241000208340 Araliaceae Species 0.000 description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 235000008434 ginseng Nutrition 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- -1 coumarin glucoside Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种持续性缓解疲劳的功能饮料,由以下重量份组分组成:山茱萸提取物:0.1~0.5份,淫羊藿提取物:0.05~0.2份,人参提取物:0.07~0.15份,牛磺酸:1~2份,灵芝提取物:0.05~0.2份,红景天提取物:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~6份,其余组成为水。本发明具有快速有效的缓解疲劳并补充能量的效果,对于因不同原因造成的疲劳问题均具有调理改善的效果,通过蔗糖转化糖增加能够延长血糖峰值时间,使能量供给时间大幅延长,长时间的血糖峰值促进饮料中的功能成分更好的发挥作用。
Description
技术领域
本发明涉及功能饮料领域,具体是一种持续性缓解疲劳的功能饮料。
背景技术
功能饮料是在一定程度上调节人体功能的饮料,具有解渴、调节肌体功能、增强免疫力等保健作用。在全民健身的大背景下,功能饮料的市场潜力巨大,并呈现平稳增长趋势。功能有助于细胞维持有氧化,减轻运动时人体的心脏负担。能充分得到更多的水分,对运动中的能量的供给和运动后体力的恢复。能有效的改善和提高代谢调节能力,补充能量。因此,功能饮料越来越受到人们的喜爱。
现有的功能饮料很多都采用了合成的药物成分或是功能成分以获得抗疲劳并补充能量的效果,这样的饮料不利于长期饮用,普通的功能饮料也不具有持续性缓解疲劳的效果。
发明内容
本发明的目的在于提供一种持续性缓解疲劳的功能饮料,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种持续性缓解疲劳的功能饮料,由以下重量份组分组成:
山茱萸提取物:0.1~0.5份,淫羊藿提取物:0.05~0.2份,人参提取物:0.07~0.15份,牛磺酸:1~2份,灵芝提取物:0.05~0.2份,红景天提取物:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~6份,其余组成为水。
作为本发明进一步的方案:所述天然香味剂为蔓越莓提取物、水蜜桃提取物、苹果提取物和柠檬提取物中的一种或多种。
作为本发明进一步的方案:所述蔗糖转化糖为异麦芽酮糖和海藻酮糖的混合物。
作为本发明进一步的方案:山茱萸提取物:0.1g,淫羊藿提取物:0.05g,人参提取物:0.07g,牛磺酸:1g,灵芝提取物:0.05g,红景天提取物:0.15g,天然香味剂:0.1g,蔗糖转化糖:4g,水:94.48g。
作为本发明进一步的方案:山茱萸提取物:0.3g,淫羊藿提取物:0.1g,人参提取物:0.1g,牛磺酸:1.5g,灵芝提取物:0.1g,红景天提取物:0.22g,天然香味剂:0.25g,蔗糖转化糖:5g,水:92.43g。
作为本发明进一步的方案:山茱萸提取物:0.5g,淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.25g。
与现有技术相比,本发明的有益效果是:具有快速有效的缓解疲劳并补充能量的效果,通过蔗糖转化糖增加能够延长血糖峰值时间,使能量供给时间大幅延长,长时间的血糖峰值促进饮料中的功能成分更好的发挥作用。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明实施例中,一种持续性缓解疲劳的功能饮料,由以下配方组成:
山茱萸提取物:0.1~0.5份,淫羊藿提取物:0.05~0.2份,人参提取物:0.07~0.15份,牛磺酸:1~2份,灵芝提取物:0.05~0.2份,红景天提取物:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~6份,其余组成为水。
在上述组分中,
山茱萸:俗名枣皮,供药用,味酸涩,性微温,为收敛性强壮药,有补肝肾止汗的功效;
淫羊藿:现代研究表明,淫羊藿含淫羊藿甙、挥发油、蜡醇、植物甾醇、鞣质、维生素E等成分;能兴奋性机能,对动物有促进精液分泌作用;还有降压(引起周围血管舒张)、降血糖、利尿、镇咳祛痰以及维生素E样作用;药理实验研究表明,淫羊藿能增加心脑血管血流量,促进造血功能、免疫功能及骨代谢,具有抗衰老、抗肿瘤等功效;
人参:主治体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神;治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之症;
牛磺酸:能够促进婴幼儿脑组织和智力发育;提高神经传导和视觉机能;防止心血管病;促进脂类的吸收;改善内分泌状态,增强人体免疫;促进糖代谢;抑制白内障的发生发展;改善记忆的功能;维持正常生殖功能;防治缺铁性贫血有明显效果,它不仅可以促进肠道对铁的吸收,还可增加红细胞膜的稳定性;牛磺酸还是人体肠道内双歧菌的促生因子,优化肠道内细菌群结构;还具有抗氧化、延缓衰老作用;能够促进急性肝炎恢复正常;对四氯化碳中毒有保护作用,并能抑制由此所引起的血清谷丙转氨酶的升高。对肾毒性有保护作用,牛磺酸对顺铂所致的兔原代肾小管上皮细胞改变有保护作用;牛磺酸可镇静、镇痛和消炎,对冻伤、KCN中毒及偏头疼也有防治作用;
灵芝:主含氨基酸、多肽、蛋白质、真菌溶菌酶(fungal lysozyme),以及糖类(还原糖和多糖)、麦角甾醇、三萜类、香豆精甙、挥发油、硬脂酸、苯甲酸、生物碱、维生素B2及C等;孢子还含甘露醇、海藻糖(trehalose);
红景天:有补气清肺、益智养心、收涩止血、散瘀消肿的功效,主治气虚体弱、病后畏寒、气短乏力、肺热咳嗽、咯血、白带腹泻、跌打损伤等。
采用上述组分制成的功能饮料,具有快速有效的缓解疲劳并补充能量的效果,对于因不同原因造成的疲劳问题均具有调理改善的效果。
实施例1
山茱萸提取物:0.1g,淫羊藿提取物:0.05g,人参提取物:0.07g,牛磺酸:1g,灵芝提取物:0.05g,红景天提取物:0.15g,天然香味剂:0.1g,蔗糖转化糖:4g,水:94.48g。
实施例2
作为本发明进一步的方案:山茱萸提取物:0.3g,淫羊藿提取物:0.1g,人参提取物:0.1g,牛磺酸:1.5g,灵芝提取物:0.1g,红景天提取物:0.22g,天然香味剂:0.25g,蔗糖转化糖:5g,水:92.43g。
实施例3
作为本发明进一步的方案:山茱萸提取物:0.5g,淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.25g。
对比例1
淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.75g。
对比例2
山茱萸提取物:0.5g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.45g。
对比例3
山茱萸提取物:0.5g,淫羊藿提取物:0.2g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.4g。
对比例4
山茱萸提取物:0.5g,淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.45g。
对比例5
山茱萸提取物:0.5g,淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,天然香味剂:0.4g,蔗糖转化糖:6g,水:90.55g。
对比例6
作为本发明进一步的方案:山茱萸提取物:0.5g,淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,水:96.25g。
下表中,对多个小白鼠分别喂食按照实施例1~3以及对比例1~6制成的功能饮料后,进行负重游泳,检测数据如下:
通过上表所示可以得出,负重游泳实验结果呈阳性,可判定本申请中配方具有缓解体力疲劳的功能,通过实施例的对比可以发现山茱萸提取物,淫羊藿提取物,人参提取物,灵芝提取物和红景天提取物的含量对于抗疲劳效果具有促进作用,通过对比例的对比可以发现,各组分均具有一定的抗疲劳效果,但多组分配合具有更好的促进作用,蔗糖转化糖的增加能够使能量供给时间大幅延长,长时间的血糖峰值促进饮料中的功能成分更好的发挥作用。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (6)
1.一种持续性缓解疲劳的功能饮料,其特征在于,由以下重量份组分组成:
山茱萸提取物:0.1~0.5份,淫羊藿提取物:0.05~0.2份,人参提取物:0.07~0.15份,牛磺酸:1~2份,灵芝提取物:0.05~0.2份,红景天提取物:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:3~5份,其余组成为水。
2.根据权利要求1所述的一种持续性缓解疲劳的功能饮料,其特征在于,所述天然香味剂为蔓越莓提取物、水蜜桃提取物、苹果提取物和柠檬提取物中的一种或多种。
3.根据权利要求1所述的一种持续性缓解疲劳的功能饮料,其特征在于,所述蔗糖转化糖为异麦芽酮糖和海藻酮糖的混合物。
4.根据权利要求1所述的一种持续性缓解疲劳的功能饮料,其特征在于,山茱萸提取物:0.1g,淫羊藿提取物:0.05g,人参提取物:0.07g,牛磺酸:1g,灵芝提取物:0.05g,红景天提取物:0.15g,天然香味剂:0.1g,蔗糖转化糖:3g,水:95.48g。
5.根据权利要求1所述的一种持续性缓解疲劳的功能饮料,其特征在于,山茱萸提取物:0.3g,淫羊藿提取物:0.1g,人参提取物:0.1g,牛磺酸:1.5g,灵芝提取物:0.1g,红景天提取物:0.22g,天然香味剂:0.25g,蔗糖转化糖:4g,水:93.43g。
6.根据权利要求1所述的一种持续性缓解疲劳的功能饮料,其特征在于,山茱萸提取物:0.5g,淫羊藿提取物:0.2g,人参提取物:0.15g,牛磺酸:2g,灵芝提取物:0.2g,红景天提取物:0.3g,天然香味剂:0.4g,蔗糖转化糖:5g,水:91.25g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810492814.XA CN108685000A (zh) | 2018-05-22 | 2018-05-22 | 一种持续性缓解疲劳的功能饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810492814.XA CN108685000A (zh) | 2018-05-22 | 2018-05-22 | 一种持续性缓解疲劳的功能饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108685000A true CN108685000A (zh) | 2018-10-23 |
Family
ID=63846859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810492814.XA Pending CN108685000A (zh) | 2018-05-22 | 2018-05-22 | 一种持续性缓解疲劳的功能饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108685000A (zh) |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1557228A (zh) * | 2004-02-12 | 2004-12-29 | 贾庆国 | 一种含灵芝、山茱萸的饮料及其制备方法 |
CN1660384A (zh) * | 2004-02-25 | 2005-08-31 | 高俊山 | 灵参红口服液及其制备方法 |
CN102048158A (zh) * | 2009-11-10 | 2011-05-11 | 天津市百奥生物技术有限公司 | 一种具有增强免疫力功效的保健食品及其制备方法 |
CN102318866A (zh) * | 2011-08-08 | 2012-01-18 | 桂林莱茵生物科技股份有限公司 | 具有缓解体力疲劳作用的饮料 |
CN103417723A (zh) * | 2012-05-18 | 2013-12-04 | 宁波海逸生物科技有限公司 | 一种具有缓解体力疲劳功能的灵淫胶囊配方 |
CN103504299A (zh) * | 2013-09-25 | 2014-01-15 | 海南正康药业有限公司 | 一种缓解体力疲劳的保健食品 |
CN103948039A (zh) * | 2014-05-14 | 2014-07-30 | 郭友用 | 一种具有缓解体力疲劳功能的保健食品及其制备方法 |
CN104000181A (zh) * | 2013-02-27 | 2014-08-27 | 北京宝德润生医药科技发展有限公司 | 一种用于缓解体力疲劳的组合物及其制备方法 |
CN104055189A (zh) * | 2014-03-14 | 2014-09-24 | 上海键源碳水化合物有限公司 | 蔗糖转化糖在功能性饮料中的应用 |
CN104224885A (zh) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | 一种缓解体力疲劳的中药组合物 |
CN104585771A (zh) * | 2014-03-06 | 2015-05-06 | 雷小康 | 一种保健饮品及其制作方法 |
CN104800313A (zh) * | 2015-04-16 | 2015-07-29 | 广州赛莱拉干细胞科技股份有限公司 | 一种抗辐射组合物及其制备方法 |
CN105168307A (zh) * | 2015-07-23 | 2015-12-23 | 广西仙草堂制药有限责任公司 | 一种提高缺氧耐受力的灵芝保健品及其制备方法 |
CN105852116A (zh) * | 2016-05-20 | 2016-08-17 | 山东明仁福瑞达制药股份有限公司 | 一种具有长效缓解体力疲劳作用的组合物及其制备方法 |
CN106619782A (zh) * | 2016-11-23 | 2017-05-10 | 山东博奥克生物科技有限公司 | 一种红景天提取物及含该提取物的健康产品 |
CN107095304A (zh) * | 2017-07-12 | 2017-08-29 | 延边韩工坊健康制品有限公司 | 一种缓解体力疲劳保健食品及其制备方法 |
-
2018
- 2018-05-22 CN CN201810492814.XA patent/CN108685000A/zh active Pending
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1557228A (zh) * | 2004-02-12 | 2004-12-29 | 贾庆国 | 一种含灵芝、山茱萸的饮料及其制备方法 |
CN1660384A (zh) * | 2004-02-25 | 2005-08-31 | 高俊山 | 灵参红口服液及其制备方法 |
CN102048158A (zh) * | 2009-11-10 | 2011-05-11 | 天津市百奥生物技术有限公司 | 一种具有增强免疫力功效的保健食品及其制备方法 |
CN102318866A (zh) * | 2011-08-08 | 2012-01-18 | 桂林莱茵生物科技股份有限公司 | 具有缓解体力疲劳作用的饮料 |
CN103417723A (zh) * | 2012-05-18 | 2013-12-04 | 宁波海逸生物科技有限公司 | 一种具有缓解体力疲劳功能的灵淫胶囊配方 |
CN104000181A (zh) * | 2013-02-27 | 2014-08-27 | 北京宝德润生医药科技发展有限公司 | 一种用于缓解体力疲劳的组合物及其制备方法 |
CN103504299A (zh) * | 2013-09-25 | 2014-01-15 | 海南正康药业有限公司 | 一种缓解体力疲劳的保健食品 |
CN104585771A (zh) * | 2014-03-06 | 2015-05-06 | 雷小康 | 一种保健饮品及其制作方法 |
CN104055189A (zh) * | 2014-03-14 | 2014-09-24 | 上海键源碳水化合物有限公司 | 蔗糖转化糖在功能性饮料中的应用 |
CN103948039A (zh) * | 2014-05-14 | 2014-07-30 | 郭友用 | 一种具有缓解体力疲劳功能的保健食品及其制备方法 |
CN104224885A (zh) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | 一种缓解体力疲劳的中药组合物 |
CN104800313A (zh) * | 2015-04-16 | 2015-07-29 | 广州赛莱拉干细胞科技股份有限公司 | 一种抗辐射组合物及其制备方法 |
CN105168307A (zh) * | 2015-07-23 | 2015-12-23 | 广西仙草堂制药有限责任公司 | 一种提高缺氧耐受力的灵芝保健品及其制备方法 |
CN105852116A (zh) * | 2016-05-20 | 2016-08-17 | 山东明仁福瑞达制药股份有限公司 | 一种具有长效缓解体力疲劳作用的组合物及其制备方法 |
CN106619782A (zh) * | 2016-11-23 | 2017-05-10 | 山东博奥克生物科技有限公司 | 一种红景天提取物及含该提取物的健康产品 |
CN107095304A (zh) * | 2017-07-12 | 2017-08-29 | 延边韩工坊健康制品有限公司 | 一种缓解体力疲劳保健食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101006817A (zh) | 一种竹叶茶及其生产方法 | |
CN102640822B (zh) | 一种保健茶膏及其制备方法 | |
CN102965235B (zh) | 一种板栗养生酒 | |
CN103589615B (zh) | 一种复方黄精太子参酒及其制备方法 | |
CN102423037B (zh) | 一种改善更年期综合症的养生粥及其制备工艺 | |
CN102578666A (zh) | 一种石斛饮料 | |
CN103549561A (zh) | 一种改善贫血体虚的保健汤 | |
CN103798473A (zh) | 延年益寿养生保健茶 | |
CN106620022A (zh) | 一种滋阴补肾壮阳的中药组合物 | |
CN102961611A (zh) | 一种保健药酒及其制备方法 | |
CN100577193C (zh) | 一种醒酒保健品 | |
CN103468504B (zh) | 一种鹿茸保健酒 | |
CN108685000A (zh) | 一种持续性缓解疲劳的功能饮料 | |
CN108685001A (zh) | 一种缓解体力疲劳补充能量的功能饮料 | |
CN104547269A (zh) | 黑豚药酒及其制作方法 | |
CN104522216A (zh) | 无糖苦丁茶饮料及其生产方法 | |
CN107625129A (zh) | 一种降血糖和降血脂的保健食品及其生产方法 | |
CN106720723A (zh) | 一种灵芝罗汉果茶及其制备方法 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN104324229A (zh) | 缓解疲劳的组合物及其制剂和应用 | |
CN108925994A (zh) | 一种铁锌钙复合维生素营养口服液及其制备方法 | |
CN104719547A (zh) | 一种凉茶饮料 | |
CN103520239A (zh) | 含有哈蟆油的软胶囊 | |
CN104413330A (zh) | 一种桂圆去火糖浆 | |
CN102308991B (zh) | 大葱油软胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181023 |
|
RJ01 | Rejection of invention patent application after publication |